Early detection of multiple myeloma: A first step towards a screening programme.
Christof ScheidCarl Ola LandgrenPublished in: British journal of haematology (2024)
Novel therapies for multiple myeloma have substantially improved the prognosis, but before patients are able to benefit from treatment, a diagnosis must have been made. The Myeloma UK laboratory working group has developed a three-part tool box to help primary care physicians to suspect myeloma despite mostly vague symptoms, to do the right tests and to derive the proper conclusions from the results. Commentary on: Drayson et al. Laboratory practice is central to earlier myeloma diagnosis; utilising a primary care diagnostic tool and laboratory guidelines integrated into haematology services. Br J Haematol 2024;204:476-486.
Keyphrases
- primary care
- multiple myeloma
- newly diagnosed
- end stage renal disease
- general practice
- ejection fraction
- healthcare
- randomized controlled trial
- transcription factor
- cross sectional
- study protocol
- physical activity
- depressive symptoms
- patient reported outcomes
- binding protein
- sleep quality
- quality improvement
- health insurance